Internal Medicine · Forest Hills, NY
NPI
1588946396
Since 2011
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
10255 63rd Rd
Forest Hills, NY, 11375
Phone (516) 262-3612
Groups this clinician bills Medicare through
Medicare paid, 2024
$137K
2,300 services
Medicare patients, 2024
173
Average age 73
Drug cost, 2024
$7.6M
17,501 prescriptions
Company payments, 2025
$4,171
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arthur Pinkhasov was code 99214 (office e&m - established), 330 times for 125 patients. In total Arthur Pinkhasov billed 2,300 services in 51 codes, and Medicare paid $137K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 330 | 125 | $111.51 | $37K |
| 99213 Office E&M - Established | Office | 285 | 116 | $77.98 | $22K |
| 99457 E&M - Miscellaneous | Office | 192 | 21 | $44.20 | $8,486 |
| 99458 E&M - Miscellaneous | Office | 181 | 20 | $36.12 | $6,538 |
| 36415 Venipuncture Blood Collection | Office | 170 | 98 | $8.65 | $1,471 |
| 99454 E&M - Miscellaneous | Office | 143 | 17 | $45.21 | $6,465 |
| 99442 Telephone Services | Office | 140 | 70 | $85.24 | $12K |
| 99212 Office E&M - Established | Office | 123 | 67 | $47.51 | $5,843 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 75 | 36 | $57.51 | $4,313 |
| 96372 Injection Administration | Office | 69 | 29 | $13.73 | $947 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 67 | 29 | $45.24 | $3,031 |
| 93000 Electrocardiogram | Office | 61 | 55 | $12.99 | $792 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 48 | 19 | $0.99 | $47.39 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 48 | 48 | $154.33 | $7,408 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 48 | 48 | $22.95 | $1,102 |
By year: 2022 $138K for 2,446 services; 2023 $139K for 2,531 services; 2024 $137K for 2,300 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 170 | 98 | $8.65 | $1,471 |
| 83036 Blood Count | 39 | 32 | $9.52 | $371 |
Medicare prescription drug claims, 2024
In 2024, the drug Arthur Pinkhasov prescribed most often to Medicare patients was Diclofenac Sodium, with 929 prescriptions and refills. In total Arthur Pinkhasov wrote 17,501 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Sodium Generic | 929 | 939 | 119 | $588K |
| Linzess Linaclotide | 648 | 678 | 80 | $342K |
| Vascepa Icosapent Ethyl | 459 | 513 | 65 | $157K |
| Myrbetriq Mirabegron | 327 | 339 | 46 | $153K |
| Rosuvastatin Calcium Generic | 325 | 397 | 55 | $1,391 |
| Amlodipine Besylate Generic | 310 | 433 | 51 | $713 |
| Zenpep Lipase/Protease/Amylase | 309 | 322 | 36 | $565K |
| Olmesartan Medoxomil Generic | 302 | 458 | 58 | $2,137 |
| Omeprazole-Sodium Bicarbonate Omeprazole/Sodium Bicarbonate | 298 | 306 | 36 | $525K |
| Atorvastatin Calcium Generic | 282 | 441 | 51 | $1,255 |
| Creon Lipase/Protease/Amylase | 278 | 288 | 38 | $388K |
| Metoprolol Succinate Generic | 261 | 328 | 41 | $1,519 |
| Jublia Efinaconazole | 242 | 245 | 33 | $319K |
| Losartan Potassium Generic | 241 | 334 | 42 | $980 |
| Restasis Cyclosporine | 224 | 228 | 30 | $140K |
Brand drugs: 7,157 claims; generic drugs: 10,046 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arthur Pinkhasov $4,171 ($4,171 in general payments such as food, travel and fees) from 31 companies. The largest payer was Amgen Inc. with $476.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 14 | $476 |
| Axsome Therapeutics, Inc. AXSM | 16 | $361 |
| Abbvie Inc. ABBV | 13 | $344 |
| Ardelyx, Inc. ARDX | 12 | $331 |
| Genzyme Corporation SNY | 5 | $287 |
| Pfizer Inc. PFE | 11 | $244 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $225 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 14 | $214 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $190 |
| Kowa Pharmaceuticals America, Inc. | 9 | $184 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.